Curated News
By: NewsRamp Editorial Staff
April 23, 2026
Urine Test Detects Bladder Cancer After Surgery, Monitors Immunotherapy
TLDR
- New urine test predicts bladder cancer treatment response, giving doctors a competitive edge in personalizing therapy.
- The urine test detects tumor DNA to identify residual bladder cancer post-surgery and assess immunotherapy effectiveness.
- This non-invasive urine test improves bladder cancer outcomes by enabling earlier detection and personalized treatment, enhancing patient quality of life.
- Urine test detects bladder cancer DNA, potentially eliminating need for invasive biopsies and monitoring treatment response.
Impact - Why it Matters
This news matters because it introduces a non-invasive urine test that could revolutionize bladder cancer management by enabling early detection of residual disease after surgery and monitoring immunotherapy effectiveness. For patients, this means potentially fewer invasive procedures and more personalized treatment adjustments. For the biotech industry, it highlights the growing role of liquid biopsies in oncology and underscores the importance of companies like Calidi Biotherapeutics in developing targeted immunotherapies.
Summary
Researchers have developed a groundbreaking urine test that can screen for tumor DNA and detect residual bladder cancer after surgery. This non-invasive test may also determine whether immunotherapy administered post-surgery has been effective or if cancer remains. As immunotherapy advances, companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI) are developing novel treatments for bladder cancer and other solid tumors. The urine test offers a potential way to monitor treatment response without invasive procedures, improving patient outcomes.
BioMedWire ("BMW") is a specialized communications platform focusing on biotechnology, biomedical sciences, and life sciences. It is part of the Dynamic Brand Portfolio @ IBN, delivering services such as wire solutions via InvestorWire, editorial syndication to 5,000+ outlets, press release enhancement, and social media distribution. BMW provides tailored corporate communications solutions to help companies reach investors, influencers, and the public. For more, visit BioMedWire.com.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Urine Test Detects Bladder Cancer After Surgery, Monitors Immunotherapy
